Hangzhou Leap Chem Co., Ltd. yog ib qho ntawm cov tuam txhab tshaj lij thiab cov neeg muag khoom ntawm 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester 丨cas 170908-81-3 hauv Suav teb. Txais tos rau kev lag luam wholesale kev cai ua cov khoom lag luam ntawm tus nqi sib tw los ntawm peb lub hoobkas. Rau cov khoom pheej yig dua, tiv tauj peb tam sim no.
Specifications
| Qhov tshwm sim | Tawm -dawb mus rau dawb khoom |
| Purity | 95% min |
| HNMR | Confirms rau tus qauv |
Daim ntawv thov
Qhov no compound, feem ntau hu ua aDOTA-NHS ester, yog ib tug tshwj xeeb chelating neeg sawv cev lug siv nyob rau hauv bioconjugation, radiopharmaceuticals, thiab molecular imaging daim ntaub ntawv. Nws yog feem ntau ua hauj lwm los txuas DOTA chelator rau biomolecules xws li peptides, tshuaj tiv thaiv kab mob, los yog cov proteins los ntawm nws cov reactive N-hydroxysuccinimide (NHS) ester pawg, tsim ruaj khov amide bonds nrog amino pawg. Hauv cov tshuaj nuclear, DOTA conjugates yog siv los chelate radiometals xws li ^68Ga, ^177Lu, lossis ^90Y, ua kom pom kev siv hluav taws xob los yog kuaj pom (PET / SPECT). Tsis tas li ntawd, nws yog siv rau hauv kev tshawb fawb rau kev npaj cov hlau-labeled biomolecules, ua kom muaj kev tshawb fawb hauv pharmacokinetics, molecular targeting, thiab bio- faib.
Cov txiaj ntsig
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester muab cov txiaj ntsig tseem ceeb vim nws qhov ua haujlwm siab, ruaj khov, thiab muaj zog hlau-chelating zog. NHS ester tso cai rau kev xaiv thiab ua tau zoo sib txuas rau thawj amines nyob rau hauv cov mob me, khaws cia cov kev ua ub no ntawm cov biomolecules rhiab heev. Lub DOTA chelator ua cov ntaub ntawv ruaj khov heev nrog ntau yam ntawm cov xov tooj cua, txo cov hlau tso tawm thiab txhim kho kev nyab xeeb hauv kev siv tshuaj yeeb tshuaj. Nws cov tshuaj stability, dej solubility, thiab reproducibility ua rau nws haum rau kuaj synthesis, preclinical kev tshawb fawb, thiab kev kho mob daim ntawv thov. Tsis tas li ntawd, nws versatility tso cai rau cov qauv tsim ntawm cov phiaj xwm duab lossis cov neeg ua haujlwm kho mob.
Xaus
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester yog ib qho tseem ceeb reagent nyob rau hauv bioconjugation, radiopharmaceutical txoj kev loj hlob, thiab molecular imaging. Nws cov txiaj ntsig, suav nrog kev xaiv amine coupling, muaj zog hlau chelation, tshuaj lom neeg ruaj khov, thiab ntau yam, ua rau nws yog ib qho tseem ceeb rau kev tsim cov phiaj xwm kuaj mob thiab kho cov neeg ua haujlwm. Kev siv txuas ntxiv ntawm qhov sib txuas no txhawb nqa kev tsim kho tshiab hauv kev kho hluav taws xob tsom, PET / SPECT imaging, thiab kev tshawb fawb biomedical advanced.
Cim npe nrov: 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester 丨cas 170908-81-3, Tuam Tshoj 1,4,7,10-tetraazacyclododecane-1,4-teaacetic acid 1-(2,5-dioxo-1-pyrrolidinyl) ester 丨cas 170908-81-3 manufacturers, lwm tus neeg, Hoobkas

